Platform
Features
Pricing
0 followers
Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.
Industries
Headquarters
Employees
Links
William Conkling
7 members
Tango Therapeutics
2 followers
Vaxcyte
Ensoma
1 follower
Aurion Biotech
Phylos
Cellares
Tyra Biosciences
Kriya Therapeutics
On Target Laboratories
Thermo Fisher Scientific
180 followers
Genentech
163 followers
Explore companies